Valérie Chamouard (Valerie Chamouard)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Randomized Controlled Trial

Glycemic Control

Patient Satisfaction

Top Venues

JMIR research protocols

JMIR formative research

Haemophilia : the official journal of the World Federation of Hemophilia

Patient preference and adherence

This page only lists publications with an associated author ORCID identifier.

Publications

Valérie Chamouard, Julie Freyssenge, Beatrice Clairaz-Mahiou, Felicia Ferrera Bibas, Laurie Fraticelli
Evaluation of an e-Learning Program for Community Pharmacists for Dispensing Emicizumab (Hemlibra) in France: Nationwide Cross-Sectional Study. JMIR formative research 8 (2024)
Valérie Chamouard, Julie Freyssenge, Beatrice Clairaz-Mahiou, Felicia Ferrera Bibas, Laurie Fraticelli
Evaluation of an e-Learning Program for Community Pharmacists for Dispensing Emicizumab (Hemlibra) in France: Nationwide Cross-Sectional Study. JMIR formative research 8 (2024)
Valérie Chamouard, Julie Freyssenge, Beatrice Clairaz-Mahiou, Felicia Ferrera Bibas, Laurie Fraticelli
Evaluation of an e-Learning Program for Community Pharmacists for Dispensing Emicizumab (Hemlibra) in France: Nationwide Cross-Sectional Study. JMIR formative research 8 (2024)
Valérie Chamouard, Julie Freyssenge, Beatrice Clairaz-Mahiou, Felicia Ferrera Bibas, Laurie Fraticelli
Evaluation of an e-Learning Program for Community Pharmacists for Dispensing Emicizumab (Hemlibra) in France: Nationwide Cross-Sectional Study. JMIR formative research 8 (2024)
Laurie Fraticelli, Julie Freyssenge, Emilie Promé-Combel, Eléonore Agnellet, Dargaud Yesim, Valérie Chamouard
Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model. JMIR research protocols 12 (2023)
Laurie Fraticelli, Julie Freyssenge, Emilie Promé-Combel, Eléonore Agnellet, Dargaud Yesim, Valérie Chamouard
Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model. JMIR research protocols 12 (2023)
Laurie Fraticelli, Julie Freyssenge, Emilie Promé-Combel, Eléonore Agnellet, Dargaud Yesim, Valérie Chamouard
Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model. JMIR research protocols 12 (2023)
Laurie Fraticelli, Julie Freyssenge, Emilie Promé-Combel, Eléonore Agnellet, Dargaud Yesim, Valérie Chamouard
Evaluation of the Care Pathway in the Context of the Dispensing of Emicizumab (Hemlibra) in Community Pharmacies in France: Protocol for a Cross-sectional Study Based on the Kirkpatrick Model. JMIR research protocols 12 (2023)
Valérie Chamouard, Julie Freyssenge, Gaetan Duport, Fabienne Volot, Rémi Varin, Nicolas Giraud, Yesim Dargaud, Laurie Fraticelli
Evaluation of the care pathway in the context of the dispensing of emicizumab (Hemlibra) in community and hospital pharmacies in France: A patient satisfaction survey. Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Victoire Pitance, Stéphanie Désage, Anne Lienhart, Sandrine Meunier, Valérie Chamouard
Haemophilia A patients' medication adherence to prophylaxis with efmoroctocog alfa. Haemophilia : the official journal of the World Federation of Hemophilia 27 (3) (2021)
Karen Beny, Benjamin du Sartz de Vigneulles, Valérie Chamouard, Ronald Guilloux, Valérie Gay, Claude Negrier, Claude Dussart
Patients' Perception of the Impact of Innovation on Hemophilia Care Management Organization: A Qualitative Study Protocol (INNOVHEMO Study). Patient preference and adherence 15 (2021)